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Abstract: While the potential impact of magnetic nanoparticles (MNPs) has been widely 
explored in almost all medical fields, including cardiology, one question remains; that is whether 
MNPs interfere with cardiac physiological processes such as the expression and function of 
ion channels, especially in vivo. KCNQ1 channels are richly expressed in cardiac myocytes and 
are critical to the repolarization of cardiac myocytes. In this study, we evaluated the effects of 
Fe3O4-magnetic nanoparticles (MNPs-Fe3O4) on the expression of KCNQ1 in cardiac muscle 
of mice at rest and at different times following a single bout of swimming (SBS). Firstly, we 
demonstrated that the expression levels of KCNQ1 channels are significantly up-regulated in 
mice following a SBS by means of reverse transcription polymerase chain reaction (RT-PCR) 
and western-blot. After treating mice with normal saline or pure MNPs-Fe3O4 separately, we 
studied the potential effect of MNPs-Fe3O4 on the expression profile of KCNQ1 in mouse cardiac 
muscle following a SBS. A SBS increased the transcription of KCNQ1 at 3 hours post exercise 
(3PE) 164% ± 24% and at 12 hours post exercise (12PE) by 159% ± 23%  (P  0.05), and 
up-regulated KCNQ1 protein 161% ± 27% at 12PE (P  0.05) in saline mice. In MNPs-Fe3O4 
mice, KCNQ1 mRNA increased by 151% ± 14% and 147% ± 12% at 3 and 12 PE, respectively 
(P  0.05). Meanwhile, an increase of 152% ± 14% in KCNQ1 protein was also detected at by 
12PE. These results indicated that the administration of MNPs-Fe3O4 did not cause any appar-
ent effects on the expression profile of KCNQ1 in rested or exercised mice cardiac muscle. Our 
studies suggest a novel path of KCNQ1 current adaptations in the heart during physical exercise 
and in addition provide some useful information for the biomedical application of MNPs which 
are imperative to advance nanomedicine.
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Introduction
Nanotechnology is at the leading edge of the rapidly developing, new therapeutic and 
diagnostic concepts in all areas of medicine.1 Nanoscale materials are a broadly defined 
set of substances in which at least one critical dimension is less than 100 nanometers.2 
The unique ability of magnetic nanoparticles (MNPs) to be functionalized with bioac-
tive agents and respond to a magnetic field has made them a useful tool for: magnetic 
resonance imaging; targeted drug and gene delivery; magnetic hyperthermia cancer 
therapy; tissue engineering, and cell tracking to name a few.3–5 Our previous study also 
proposed that daunorubicin-loaded magnetic nanoparticles of Fe3O4 (MNPs-Fe3O4) 
can overcome the multi-drug resistance of certain carcinoma cells, both in vitro and 
in vivo.6–8 While mounting evidence suggests that MNPs have numerous advanced 
applications and the benefits of nanotechnology are widely publicized, in vivo data on International Journal of Nanomedicine 2010:5 110
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the potential effects of pure MNPs on mammals are limited. 
An understanding of the interface between the MNPs and 
specific organs, for to their application and safety, are impera-
tive to advance nanomedicine. Although there are several 
reports showing that MNPs may be accumulated in tissues 
when administered at clinically relevant concentrations, via 
relevant routes, show unremarkable histological changes in 
vital organs, suggesting their safety in the respective for-
mulations to some degree.9,10 However information on the 
physiological function of vital organs after the administration 
of MNPs is rarely reported.
The heart is a rhythmic electro-mechanical pump, the 
functioning of which depends on action potential (AP) 
generation and propagation, followed by relaxation and a 
period of refractoriness until the next impulse is generated. 
Cardiac repolarization is a key cellular function. Disruption 
of cardiac repolarization leads to potentially lethal ventricular 
tachyarrhythmias. Delayed rectifier K+ current (IK) is the 
major outward current involved in ventricular repolarization. 
Two components of IK, the rapid voltage-gated potassium 
current, IKr and slow voltage-gated potassium current, IKs, 
have been identified. A prolongation of APs under a variety 
of conditions would favor the activation of IKs so as to prevent 
excessive repolarization delay, causing early depolarization. 
The pore-forming subunit of the voltage-dependent K+ chan-
nel underlying IKs is KCNQ1.11
The KCNQ1 is a 6-transmembrane protein that can either 
form a functional homomeric potassium channel or coassem-
ble with the single transmembrane domain protein encoded by 
the KCNE family of genes to form a heteromeric channel, the 
slow voltage-gated potassium channel (IKs channel).12,13 Muta-
tions in the cardiac KCNQ1 have been linked to the long QT 
syndrome (LQTS)1, which predisposes patients to arrhythmia 
during exercise and emotional stress, conditions that involve 
high levels of sympathetic nervous system activity.14,15
Stimulation of the sympathetic nervous system (SNS) 
in response to exercise or emotional stress results in a rapid 
and dramatic increase in heart rate. To ensure adequate 
diastolic filling time between beats, the ventricular action 
potential duration (APD) exhibits a concomitant shortening 
at the cellular level, which results in a reduction in the cor-
responding QT interval of the electrocardiography (ECG). 
The enhancement of slow voltage-gated potassium current 
IKs plays a major role in this process.16 Although some reports 
show that the activity of IKs channel can be upregulated in 
the face of elevated SNS activity.16,17 It is currently unknown 
whether the remodeling of IKs channel expression may be 
induced by the stimulation of exercise.
In this study, we investigated the expression profile of 
KCNQ1 in mouse cardiac muscle following a single bout 
of swimming (SBS). In order to assess the potential effects 
of pure MNPs on mammal heart, we also treated mice with 
normal saline or MNPs-Fe3O4 separately and then examined 
the effects of MNPs-Fe3O4 on the expression of KCNQ1 in 
exercised and non-exercised mouse heart. MNPs-Fe3O4 have 
not been found to downregulate the apoptosis-associated 
genes in certain carcinoma cells.7
Material and methods
Preparation of MNPs-Fe3O4
MNPs-Fe3O4 were produced by electrochemical deposition under 
oxidizing conditions in a 0.1 mol/L tetraheptylammonium-2-
propanol solution, in which the magnetization and particle 
size of MNPs-Fe3O4 were found to be 25.6 × 10−3 emu/mg 
and 30 nm, respectively.18 The deposited clusters were capped 
with tetraheptylammonium-2-propanol, which acts as a 
stabilizer of the colloidal nanocrystallites.19 Before being 
applied in this experiment, the magnetized nanoparticles of 
Fe3O4 were well distributed in 0.9% NaCl solution by using 
ultrasound treatment in order to obtain colloidal suspension 
of MNPs-Fe3O4.18
Animals
Four-week-old, male BALB/c-nu/nu mice were purchased 
from Beijing National Center for Laboratory Animals, the 
Chinese Academy of Medical Sciences prior to the begin-
ning of our experiments. Both food and water were provided 
ad libitum.
exercise protocols
Forty-two mice were randomly assigned to either the non-
exercised control group (n = 6) or exercise groups (n = 36). 
Thirty-six mice were placed into plastic cylinders (23 cm 
tall × 14 cm diameter) containing water (22–24°C) filled 
to a depth of 15 cm for a 30-minute swim. Non-exercised 
controls were kept in their home cage for the duration of the 
test. Mice completing the exercise were euthanized via cervi-
cal dislocation immediately or at 1, 3, 6, 12, or 24 hour after 
exercise. Until euthanasia, food and water were provided 
ad libitum. The ventricles were quickly dissected from each 
mouse, frozen in liquid nitrogen, and stored at −80°C until 
assayed.
For the study of the MNPs-Fe3O4, 48 mice were assigned 
randomly into 2 groups (n = 24) and treated with normal 
saline 0.2 mL or MNPs-Fe3O4 (0.2 mL, 0.58 mg/kg) every 
other day for 14 day by vena caudalis injection, respectively. International Journal of Nanomedicine 2010:5 111
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Mice treated with normal saline or MNPs-Fe3O4 were then 
randomly assigned to either non-exercised control group 
(n = 6) or the exercise groups (n = 18) respectively. Mice 
were exposed to a 30-minute swim 1 day after the last injec-
tion. All experiments were conducted at approximately the 
same time of day. After completing the exercise the mice 
were euthanized via cervical dislocation at 3, 12, or 24 hour 
after exercise (Table 1). Until euthanasia, food and water 
were provided ad libitum.
semiquantitative polymerase chain 
reaction (PcR)
The dissected left ventricles were crushed into a fine powder 
using a mortar and pestle. Total RNA was extracted using 
TRIzol® (Invitrogen, Carlsbad, CA, USA), and RNA concen-
trations were determined spectrophotometrically at 260 nm. 
RNA was treated with DNase to eliminate potential genomic 
DNA contamination, and reverse transcription and polymerase 
chain reaction (PCR) were performed with 1 µg of total RNA 
using ReverTraAce® a (Toyobo, Osaka, Japan). cDNAs were 
amplified by PCR in a Bio-Rad Mycycler thermal cycler. PCR 
was undertaken with triplicate samples prepared from each 
animal, in each group. Each reaction contained 500 ng cDNA. 
The PCR primers used were as: KCNQ1 (525bp) forward 
primer, 5′-CACTTCACCGTCTT CCTCATT-3′; reverse, 5′-
TCTGCGTAGC TGCCAAACT-3′; β-actin (360bp) forward 
primer, 5′-TTGCAGCTCCTTC GTTGCCG-3′; reverse, 
5′-GCCTCGGTG AGCAGCACAGG-3′. Cycle times used 
for each primer pair were within the linear increase in PCR 
product. PCR products were separated and visualized in 
1.5% agarose gels with ethidium bromide. Band intensities 
of KCNQ1 were quantitated using ImageQuant™ software and 
normalized to β-actin.
Western blot analysis
Left ventricular tissue was homogenized with 500 µL 
lysis buffer (100 mM/L Tris [pH 6.8], 4% sodium dodecyl 
sulfate [SDS], 20% glycerol) containing the protease inhibitor 
phenylmethanesulfonyl fluoride 0.1 mM/L. We separated 
50 µg of proteins on SDS–polyacrylamide gel electrophoresis 
10%. Proteins were transferred to nitrocellulose membrane 
(Bio-Rad Laboratories, Hercules, CA, USA) blocked with 
5% dry milk and exposed to rabbit polyclonal antibody anti-
KCNQ1 (H-130: sc-20816, [Santa Cruz Biotechnology, Santa 
Cruz, CA USA]; dilution 1:2,000 in bovine serum albumin 
(BSA) 5%), rabbit polyclonal antibody anti-β-actin (ab8227, 
[Abcam, Cambridge, MA, USA]; dilution 1:5,000 in BSA 5%). 
Immunodetection was accomplished using goat anti-rabbit IgG 
(Sigma-Aldrich, St. Louis, MO, USA) secondary antibodies 
(dilution 1:4,000 in BSA 5%), and a chemiluminescence kit 
(Amersham Biosciences, Little Chalfont, Buckinghamshire, 
UK). Band intensities were analyzed by densitometry. Band 
intensities of KCNQ1 were normalized to β-actin.
statistical analysis
All data are expressed as means ± SE. The effect of swimming 
on expression of KCNQ1 was analyzed using one-way analysis 
of variance (ANOVA). Two-way ANOVA was used for 
Fe3O4 administration studies.
Results
Acute exercise enhanced KcNQ1 mRNA 
and protein expression in mouse cardiac 
muscle
Compared to mice in the non-exercise control group (basal), 
a 30-minute single bout of swimming enhanced the transcrip-
tion of KCNQ1 mRNA in the heart at 3, 6, and 12 hour post 
exercise (PE) (P  0.05, Figure 1). The expression level of 
KCNQ1 mRNA returned to approximately control levels 
within 24-PE.
Expression of KCNQ1 protein significantly increased with 
exercise in mice at 12PE compared with the non-exercised 
basal animals (P  0.05, Figure 2), and the amount of KCNQ1 
protein decreased nearly to base level at 24PE.
effect of Fe3O4 magnetic nanoparticles 
on acute exercise enhanced KcNQ1 
expression in mouse cardiac muscle
Over the course of the 14-day treatment with normal saline 
or MNPs-Fe3O4, mice showed no significant health problems. 
Drug administration also did not appear to affect exercise 
performance.
The amount of KCNQ1 mRNA increased significantly at 
3PE and 12PE compared to basal animals (P  0.05) both in 
Table 1 Number of mice in each group for the study of the 
MNPs-Fe3O4
Groups Treated with 
saline (n)
Treated with 
MNPs-Fe3O4 (n)
Non-exercised control group 6 6
exercise  
groups
euthanized at 3Pe 6 6
euthanized at 12Pe 6 6
euthanized at 24Pe 6 6
Abbreviation: Pe, post exercise.International Journal of Nanomedicine 2010:5 112
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Figure 1 effect of a single bout of exercise on the transcription of KcNQ1 mRNA.
Notes: All values are reported as means ± se (n = 6). *P  0.05, the expression levels of KcNQ1 at 3PE, 6PE and 12PE were significantly different from the basal group.
Abbreviation: Pe, post exercise.
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Figure 2 effect of a single bout of exercise on the expression of KcNQ1 protein.
Notes: All values are reported as means ± se (n = 6). *P  0.05, the expression level of KcNQ1 at 12PE was significantly different from the basal group.
Abbreviation: Pe, post exercise.International Journal of Nanomedicine 2010:5 113
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saline and MNPs-Fe3O4 group (Figure 3, Table 2). Expression 
of KCNQ1 protein also increased significantly at 12PE when 
compared to basal animals (P  0.05) both in saline and 
MNPs-Fe3O4 group (Figure 4, Table 2).
No significant differences were found in KCNQ1 
expression profile between MNPs-Fe3O4 mice and con-
trol saline mice at rest or post exercise (Figures 3 and 4, 
Table 2).
Discussion
The present study examined firstly the effect of a single bout 
of swimming on the expression of KCNQ1 in mouse cardiac 
muscle. Our data shows a 30-minute bout of swimming 
enhanced KCNQ1 expression at 3PE and 12PE. Admin-
istrations of MNPs-Fe3O4 had no significant influence or 
enhancement effect of acute exercise on KCNQ1 expression 
in mouse cardiac muscle.
Cardiac APs are driven by ionic currents flowing through 
specific channels and exchangers across cardiomyocyte 
membranes. Voltage-gated K+ currents play a major role in 
repolarization of APs. KCNQ1 is a 6-transmembrane domain 
protein that can form the slow voltage-gated potassium chan-
nel (IKs channel) constituting the slowly activating potassium 
current IKs. There is a growing number of studies that sug-
gest that the IKs is important for AP repolarization and APD 
adaptation to changes in heart rate.16,17 The importance of the 
KCNQ1 channel at fast heart rates is especially evident from 
the fact that exercise or emotional stress conditions, which 
involve high levels of beta-adrenergic stimulation, trigger 
arrhythmias in more than 80% of patients with the long QT 
syndrome (LQTS) which arise from mutations in KCNQ1.20 
The activation of β-adrenergic receptors can regulate select 
ion channel proteins via cAMP-dependent protein kinase A 
(PKA) or by direct binding of cAMP to channel subunits. 
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Figure 3 effect of Fe3O4-magnetic nanoparticles on the transcription of acute exercise enhanced KcNQ1 mRNA in mouse cardiac muscle.
Notes: All values are reported as means ± se (n = 6). *P  0.05, the transcriptions level of KcNQ1 at 3PE and 12PE in saline mouse was significantly different from the basal 
group. #P  0.05, the transcriptions level of KcNQ1 at 3Pe and 12Pe in mouse treated with MNPs-Fe3O4 were significantly different from the basal group.
Abbreviation: Pe, post exercise.International Journal of Nanomedicine 2010:5 114
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One key substrate for PKA-dependent phosphorylation in the 
regulation of the cardiac action potentials is the IKs channel.21 
Augmentation of IKs current by β-adrenergic stimulation plays 
an important role in mediating cardiac electrophysiological 
response during exercise and emotional stress.16 Despite the 
elucidation of the macromolecular signaling complex and 
striking clinical data, the possibility that exercise might induce 
remodeling of IKs channel expression has not been tested.
Our present results show that the transcription and expression 
of KCNQ1 are increased following a 30-minute swimming. 
These data indicate the remodeling of KCNQ1 expression 
that might partially compensate for the shortening of cardiac 
action potential duration; which results in a reduction in the 
corresponding QT interval of the elctrocardiogram.22
The potential benefits of nanotechnology in medicine 
are inevitable, owing to refined, highly targeted: blood-brain 
Table 2 effect of MNPs-Fe3O4 on change of KcNQ1 expression in mouse cardiac muscle
Group Change of KCNQ1 mRNA (%) Change of KCNQ1 protein (%)
Saline MNPs-Fe3O4 P value Saline MNPs-Fe3O4 P value
3Pe 164 ± 24 151 ± 14 0.64 129 ± 11 136 ± 21 0.80
12Pe 159 ± 23 147 ± 12 0.66 161 ± 27 152 ± 14 0.76
24Pe 119 ± 17 110 ± 10 0.67 112 ± 9 116 ± 15 0.84
Notes: All values of change are compared to corresponding basal and are reported as means ± se (n = 6). P  0.05. P values are for comparison of MNPs-Fe3O4 group with 
corresponding saline group.
Abbreviations: se, standard error; Pe, post exercise.
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Figure 4 effect of Fe3O4-magnetic nanoparticles on the expression of acute exercise enhanced KcNQ1 protein in mouse cardiac muscle.
Notes: All values are reported as means ± se (n = 6). *P  0.05, the expression level of KcNQ1 at 12PE in saline mouse was significantly different from the basal group. 
#P  0.05, the expression level of KcNQ1 protein at 12Pe in mouse treated with MNPs-Fe3O4 was significantly different from the basal group.
Abbreviation: Pe, post exercise.International Journal of Nanomedicine 2010:5 115
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barrier-crossing drug delivery and imaging platforms; unique 
transfection; labeling and bioseparation, together with ana-
lytical and tissue engineering approaches. The versatility of 
MNPs is due to their capability of responding to an external 
magnetic field and can be functionalized with bioactive 
agents at the same time and/or differentially.23 For successful 
application of MNPs, it is essential to understand the real 
effect of the pure MNPs on vital organs and cells.
MNP size, charge, surface chemistry and route of delivery 
each influence their effective time and biodistribution pat-
terns in the body.25 Large (200 nm) particles are usually 
sequestered by the spleen via mechanical filtration followed 
by phagocytosis, whereas smaller (10 nm) particles are rap-
idly removed through extravasation and renal clearance, with 
particles 10–100 nm believed to be optimal for intravenous 
administration.25 In this study, pure MNPs-Fe3O4 (30 nm) 
were used for the evaluation of their potential effect on the 
protein expression in the heart as well as exercise ability. The 
results showed that pure MNPs did not cause any apparent 
effects on swimming behavior nor in the KCNQ1 expression 
profile before or after exercise.
Conclusion
In conclusion, our results indicate a novel path of IKs current 
adaptations in the heart during physical exercise. Compared 
with mice in the non-exercise control group expression of 
KCNQ1 in the heart were significantly increased following 
exercise. Therefore, not only the increased activity but also 
the enhanced expression of KCNQ1 channel might contribute 
to current MNP-Fe3O4 adaptations in the face of elevated 
sympathetic nervous system activity. Further study shows 
that the administration of MNPs-Fe3O4 has no significant 
influence on the expression profile of KCNQ1 in rested or 
in exercised mice cardiac muscle. These data might provide 
some useful information required to improve MNP formula-
tions and biomedical applications which are imperative to 
advance nanomedicine.
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